Enveric Biosciences, Inc. (ENVB) Stock Declines While Market Improves: Some Information for Investors [Yahoo! Finance]
Enveric Biosciences, Inc. (ENVB)
Company Research
Source: Yahoo! Finance
The stock trailed the S&P 500, which registered a daily gain of 1.02%. Elsewhere, the Dow saw an upswing of 0.4%, while the tech-heavy Nasdaq appreciated by 2.03%. Coming into today, shares of the company had lost 10% in the past month. In that same time, the Medical sector lost 5.2%, while the S&P 500 lost 3.15%. The investment community will be closely monitoring the performance of Enveric Biosciences, Inc. in its forthcoming earnings report. The company is predicted to post an EPS of -$0.61, indicating a 72.52% growth compared to the equivalent quarter last year. Investors should also note any recent changes to analyst estimates for Enveric Biosciences, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability. Our research suggests that these changes in estimates have a direct relationship with upcoming stock
Show less
Read more
Impact Snapshot
Event Time:
ENVB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ENVB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENVB alerts
High impacting Enveric Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
ENVB
News
- Enveric Biosciences to out-license psilocin prodrug to MindBio [Yahoo! Finance]Yahoo! Finance
- Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results [Yahoo! Finance]Yahoo! Finance
- Enveric Biosciences Reports First Quarter 2024 Financial and Corporate ResultsBusiness Wire
- Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders [Yahoo! Finance]Yahoo! Finance
- Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders [Yahoo! Finance]Yahoo! Finance
ENVB
Sec Filings
- 5/15/24 - Form 10-Q
- 5/15/24 - Form 8-K
- 5/3/24 - Form 424B5
- ENVB's page on the SEC website